Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: clinical trials

November 30, 2023 Drug delivery / Pharma applications

Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products

Novel cyclodextrin derivatives, such as polyrotaxanes, cyclodextrin-polymer conjugates, and thiolated cyclodextrins, are among the most promising candidates in drug delivery.

Continue reading

June 22, 2023 CD as API / Pharma applications

Serving patient’s safety and comfort: Effects of sugammadex vs. neostigmine on postoperative nausea, vomiting and pulmonary complications following general anesthesia.

A recent study published by Korean scientists compared the effect of sugammadex with that of neostigmine in terms of the

Continue reading

July 12, 2022 CD as API / Events / Pharma applications

Cyclo Therapeutics to Present at the 2022 NPC Patient and Family Conference Hosted by the Australian NPC Disease Foundation

Presentation by Professor Caroline Hastings, MD, Chair of the Phase 3 Trappsol® Cyclo™ Program Steering Committee and the Global Principal Investigator

Continue reading

April 11, 2022 Drug delivery / Pharma applications

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir

The aim of this report is to review the literature and shed light on the uncertainties surrounding the use of

Continue reading

March 14, 2022 CD as API / Pharma applications

Cyclo Therapeutics on Phase 3 Clinical Development Program for Trappsol® Cyclo™ in Niemann-Pick Disease Type C

Businesswire published: Cyclo Therapeutics Announces Formation of Global Steering Committee Comprised of Leading Experts to Advise on the Global Phase

Continue reading

February 15, 2021 Drug delivery / Pharma applications

Reviews on remdesivir in Covid-19 treatment

Remdesivir (GS-5734; Gilead Sciences Inc., US) is an investigational nucleoside analog that acts as a competitive inhibitor of viral RNAdependent

Continue reading

October 19, 2020 Drug delivery / Pharma applications

Gilead debates WHO results on low effectivity of remdesivir in Covid-19 mortality rate

Pharmafile reports that Gilead’s antiviral therapy remdesivir has emerged as one of the most promising drugs to treat COVID-19 infections,

Continue reading

August 27, 2020 Pharma applications

Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis

The systematic review published recently in Clinical Microbiology and Infection was based on  29 articles [1]. All studies except one

Continue reading

July 24, 2020 Pharma applications

Two coronavirus vaccines show immune response in human trials

Advanced Science News published on the results of clinical trials of two vaccines against SARS-CoV-2. Three months ago, the University of

Continue reading

June 17, 2020 Drug delivery / Pharma applications

Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence

In a pandemic like Covid-19 the urgent need excludes the development of new drugs, “conventional drug in new use” becomes

Continue reading

Posts navigation

1 2 Next Posts»

Recent Posts

  • Low melting mixtures: Neoteric green solvents for flavor formulation
  • Cyclodextrins as molecular carriers for biopesticides: a review
  • International Meet on Cell Science and Molecular Biology
  • Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products
  • Website registration and abstract submission for 21st International Cyclodextrin Symposium open

Tags

alpha-CD Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (18)
  • Analysis (40)
  • CD as API (234)
  • CD derivatives (290)
  • Cosmetics and toilettry (23)
  • Diagnosis (3)
  • Drug delivery (513)
  • E-ducation (59)
  • Environmental (85)
  • Events (175)
  • Food (145)
  • Gene delivery (12)
  • In Hungarian (4)
  • Life sciences (25)
  • Non-pharma applications (259)
  • Other industrial use (74)
  • Pharma applications (802)
  • Supramolecular systems (30)
  • Uncategorized (62)

Top Posts

  • Australian company pioneering Cavadextrin for regression of atherosclerosis
  • Lanosterol eye drops for cataract treatment
  • Call for Book Chapters in Book "Cyclodextrins in Chemosensing" (Springer Nature)
  • 16th Annual World Cancer Congress
  • Cyclodextrins as molecular carriers for biopesticides: a review
  • The Biological Fate of Pharmaceutical Excipient β-Cyclodextrin: Pharmacokinetics, Tissue Distribution, Excretion, and Metabolism of β-Cyclodextrin in Rats
  • Low melting mixtures: Neoteric green solvents for flavor formulation
  • Wasabi's bioactive component 6-MSITC formulated with alfa-cyclodextrin improved memory proven in clinical trial.
  • Website registration and abstract submission for 21st International Cyclodextrin Symposium open
  • Are cyclodextrins safe for intravitreal injections?

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 570 other subscribers
 

Loading Comments...